Cargando…

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs

Tuberculosis remains as a serious infection disease of worldwide distribution, with high morbidity and mortality, mainly in low socio-economic condition countries. The state of emergency of tuberculosis caused by the resistant and multidrug-resistant (MDR) strains, became the main threat to the tube...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchotene, Karine O., von Groll, Andrea, Ramos, Daniela, Scholante, Ana B., Honscha, Gunther, Valença, Mariana, Scaini, Carlos J., da Silva, Pedro E.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Microbiologia 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768376/
https://www.ncbi.nlm.nih.gov/pubmed/24031169
http://dx.doi.org/10.1590/S1517-83822008000100004
_version_ 1782283768980045824
author Sanchotene, Karine O.
von Groll, Andrea
Ramos, Daniela
Scholante, Ana B.
Honscha, Gunther
Valença, Mariana
Scaini, Carlos J.
da Silva, Pedro E.A.
author_facet Sanchotene, Karine O.
von Groll, Andrea
Ramos, Daniela
Scholante, Ana B.
Honscha, Gunther
Valença, Mariana
Scaini, Carlos J.
da Silva, Pedro E.A.
author_sort Sanchotene, Karine O.
collection PubMed
description Tuberculosis remains as a serious infection disease of worldwide distribution, with high morbidity and mortality, mainly in low socio-economic condition countries. The state of emergency of tuberculosis caused by the resistant and multidrug-resistant (MDR) strains, became the main threat to the tuberculosis treatment and control programs. A fast detection method for the resistant strains will allow the implementation of an adequate treatment and contribute for controlling the dissemination of these resistant strains. This study evaluated the performance of the nitrate reductase assay in solid (NRA-LJ) and liquid (NRA-7H9) media, to determine the susceptibility to first line anti-tuberculosis drugs: isoniazid (INH), rifampicin (RMP), ethambutol (EMB) and streptomycin (SMR). Both methods NRA-LJ and NRA-7H9 were evaluated among 18 strains with a known susceptibility profile. The resazurin microtiter assay (REMA) was performed as a reference method. One hundred percent of accordance was observed between NRA-7H9 and REMA for the four tested drugs. When the NRA-LJ method was compared to REMA, the sensitivity and the specificity to INH, RMP, EMB and SMR were 100%, 100 %, 85.7%, 76.9% and 80%, 100%, 75% and 80%, respectively. From the 57 clinical isolates of M. tuberculosis evaluated by NRA-7H9 and REMA, 56 (98.2%) were sensitive to all antibiotics tested (INH, RMP, EMB and SMR) by the NRA-7H9 method, while three of these strains were resistant to INH by REMA. One strain showed resistance to INH and RMP for both methods, and MIC of 1.0 μg/ml to INH for both methods, while MIC of 1.0 and 2.0 μg/ml to RMP for REMA and NRA-7H9, respectively. The three assays showed a high level of agreement for rapid detection of rifampicin and isoniazid resistance. Regarding rapidness, the detection of color change in the NRA method is within instants as compared to the overnight incubation required for the REMA test. NRA might represent an inexpensive and alternative assay for rapid detection of resistance in low-income countries.
format Online
Article
Text
id pubmed-3768376
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Sociedade Brasileira de Microbiologia
record_format MEDLINE/PubMed
spelling pubmed-37683762013-09-12 Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs Sanchotene, Karine O. von Groll, Andrea Ramos, Daniela Scholante, Ana B. Honscha, Gunther Valença, Mariana Scaini, Carlos J. da Silva, Pedro E.A. Braz J Microbiol Medical Microbiology Tuberculosis remains as a serious infection disease of worldwide distribution, with high morbidity and mortality, mainly in low socio-economic condition countries. The state of emergency of tuberculosis caused by the resistant and multidrug-resistant (MDR) strains, became the main threat to the tuberculosis treatment and control programs. A fast detection method for the resistant strains will allow the implementation of an adequate treatment and contribute for controlling the dissemination of these resistant strains. This study evaluated the performance of the nitrate reductase assay in solid (NRA-LJ) and liquid (NRA-7H9) media, to determine the susceptibility to first line anti-tuberculosis drugs: isoniazid (INH), rifampicin (RMP), ethambutol (EMB) and streptomycin (SMR). Both methods NRA-LJ and NRA-7H9 were evaluated among 18 strains with a known susceptibility profile. The resazurin microtiter assay (REMA) was performed as a reference method. One hundred percent of accordance was observed between NRA-7H9 and REMA for the four tested drugs. When the NRA-LJ method was compared to REMA, the sensitivity and the specificity to INH, RMP, EMB and SMR were 100%, 100 %, 85.7%, 76.9% and 80%, 100%, 75% and 80%, respectively. From the 57 clinical isolates of M. tuberculosis evaluated by NRA-7H9 and REMA, 56 (98.2%) were sensitive to all antibiotics tested (INH, RMP, EMB and SMR) by the NRA-7H9 method, while three of these strains were resistant to INH by REMA. One strain showed resistance to INH and RMP for both methods, and MIC of 1.0 μg/ml to INH for both methods, while MIC of 1.0 and 2.0 μg/ml to RMP for REMA and NRA-7H9, respectively. The three assays showed a high level of agreement for rapid detection of rifampicin and isoniazid resistance. Regarding rapidness, the detection of color change in the NRA method is within instants as compared to the overnight incubation required for the REMA test. NRA might represent an inexpensive and alternative assay for rapid detection of resistance in low-income countries. Sociedade Brasileira de Microbiologia 2008 2008-03-01 /pmc/articles/PMC3768376/ /pubmed/24031169 http://dx.doi.org/10.1590/S1517-83822008000100004 Text en © Sociedade Brasileira de Microbiologia http://creativecommons.org/licenses/by-nc/3.0/ All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License
spellingShingle Medical Microbiology
Sanchotene, Karine O.
von Groll, Andrea
Ramos, Daniela
Scholante, Ana B.
Honscha, Gunther
Valença, Mariana
Scaini, Carlos J.
da Silva, Pedro E.A.
Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title_full Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title_fullStr Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title_full_unstemmed Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title_short Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
title_sort comparative evaluation of the nitrate reductase assay and the resazurin microtitre assay for drug susceptibility testing of mycobacterium tuberculosis against first line anti-tuberculosis drugs
topic Medical Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768376/
https://www.ncbi.nlm.nih.gov/pubmed/24031169
http://dx.doi.org/10.1590/S1517-83822008000100004
work_keys_str_mv AT sanchotenekarineo comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT vongrollandrea comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT ramosdaniela comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT scholanteanab comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT honschagunther comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT valencamariana comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT scainicarlosj comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs
AT dasilvapedroea comparativeevaluationofthenitratereductaseassayandtheresazurinmicrotitreassayfordrugsusceptibilitytestingofmycobacteriumtuberculosisagainstfirstlineantituberculosisdrugs